Rinvoq ER 45 MG tablet UU 28S
Ended Awarded Last action
- Contract number
- SPE2DR26FP8ZT
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $116,867
Award facts
- Contract value 100% obligated
- $116,866.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On January 28, 2026, the Defense Logistics Agency awarded a delivery order valued at $116,866.60 to AmerisourceBergen Drug Corp for RINVOQ ER 45 mg tablets (28-tablet units). This firm fixed-price contract, with an ultimate completion date of January 29, 2026, represents a non-set-aside award issued under open competition. The work will be performed at the awardee's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems.
This delivery order operates as a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. The IDC enables the company to supply an expansive portfolio of pharmaceutical products and medical commodities across multiple therapeutic domains to support military healthcare programs worldwide, including medications, vaccines, and specialized medical supplies. The award of this RINVOQ order reflects the contractor's established capability to efficiently fulfill government contracts for essential pharmaceutical commodities required by military treatment facilities and other federal medical institutions.
Quick answers
Who was awarded contract SPE2DR26FP8ZT?
SPE2DR26FP8ZT was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26FP8ZT worth?
The government has obligated $116,867 on SPE2DR26FP8ZT.
Is contract SPE2DR26FP8ZT an order under another contract?
Yes. SPE2DR26FP8ZT is a delivery order under SPE2DR25D3005, an indefinite delivery contract.
Was contract SPE2DR26FP8ZT competed?
The extent of competition for SPE2DR26FP8ZT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award